The Medical Letter on Drugs and Therapeutics Product Image

The Medical Letter on Drugs and Therapeutics

  • ID: 2105348
  • May 2015
  • Medical Letter

Prescription Drug Information And Drug Facts Since 1959

The Medical Letter is a peer-reviewed biweekly publication which provides:

- Unbiased critical evaluation of FDA-approved drugs, with a special emphasis on new drugs.
- Appraisal of new drugs for effectiveness, toxicity and cost, and discussion of possible alternatives.
- An occasional review of a new non-drug treatment or a new diagnostic aid.

The editorial process relies on a consensus of experts to ensure the information in our articles is presented in a balanced and scientifically supported manner.

Your subscription to The Medical Letter includes:

- Print version published and mailed biweekly (26 issues/year)
- Online access to current issue and archives from 1988 to the present
- The Mobile Collection for your smartphone:
- Access your subscription from your smartphone on a mobile site or download a free app for iPad, iPhone, iPod Touch, Android and Kindle Fire
- FREE online per issue CME/CE

26 issues/year

Note: Product cover images may vary from those shown
Note: Product cover images may vary from those shown


  • Quick Help: This Subscription product will be emailed to you. The title is sent in PDF format. This is a single user license, allowing one specific user access to the product.


If you have a more general question about our products please try our



Our Clients

  • Pfizer, Inc.
  • Grünenthal GmbH
  • GlaxoSmithKline PLC
  • Abbott Laboratories Ltd.
  • Roche Diagnostics Ltd.
  • Novo Nordisk A/S